Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

RVMD holding history

Revolution Medicines, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RVMD overviewAll 13F holders of RVMDFull Q2 2026 holdings

Shares (Q2 2026)
12,400
Value
$2.32M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of RVMD by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,400$2.32M<0.1%−1,009,898−98.8%ReducedHolders
Q1 20261,022,298$99.4M0.1%−591,432−36.6%ReducedHolders
Q4 20251,613,730$128.5M0.1%+801,451+98.7%AddedHolders
Q3 2025812,279$37.9M<0.1%+152,147+23.0%AddedHolders
Q2 2025660,132$24.3M<0.1%+660,132NewHolders
Q1 20250$00.0%−14,831−100.0%Sold outHolders
Q4 202414,831$648.7K<0.1%−25,178−62.9%ReducedHolders
Q3 202440,009$1.81M<0.1%+10,715+36.6%AddedHolders
Q2 202429,294$1.14M<0.1%−44,363−60.2%ReducedHolders
Q1 202473,657$2.37M<0.1%+22,584+44.2%AddedHolders
Q4 202351,073$1.46M<0.1%−694,198−93.1%ReducedHolders
Q3 2023745,271$20.6M<0.1%+301,697+68.0%AddedHolders
Q2 2023443,574$11.9M<0.1%+246,741+125.4%AddedHolders
Q1 2023196,833$4.26M<0.1%+134,759+217.1%AddedHolders
Q4 202262,074$1.48M<0.1%−126,182−67.0%ReducedHolders
Q3 2022188,256$3.71M<0.1%+188,256NewHolders
Q1 20220$00.0%−19,541−100.0%Sold outHolders
Q4 202119,541$492.0K<0.1%+19,541NewHolders
Q3 20210$00.0%−17,492−100.0%Sold outHolders
Q2 202117,492$555.0K<0.1%−3,317−15.9%ReducedHolders
Q1 202120,809$955.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.